Inactive

This is a Solicitation Notice. This is a solicitation for proposals in accordance with FAR Part 15. The solicitation number for this requirement is 75D301-21-R-71814 Please refer to the attached RFP d... This is a Solicitation Notice. This is a solicitation for proposals in accordance with FAR Part 15. The solicitation number for this requirement is 75D301-21-R-71814 Please refer to the attached RFP document. 6/25/2021: Amendment 1 was posted

Inactive

The Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) has a requirement for a contract to conduct a multicenter epidemio... The Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) has a requirement for a contract to conduct a multicenter epidemiologic research study using the principles of implementation science to identify the characteristics of latent tuberculosis infection (LTBI) targeted testing and treatment programs that are associated with the greatest effectiveness (maximizing number of LTBI cases detected and completely treated according to CDC guidelines) and efficiency (minimizing the cost per LTBI case detected and completely treated). CDC, through its TB Epidemiologic Studies Consortium (TBESC), aims to 1) identify primary care systems/settings that serve non-U.S.–born persons at risk for LTBI and TB disease, 2) collect retrospective and prospective electronic medical record data, 3) design and implement clinical care-based interventions to improve performance measures across the LTBI care cascade, and 4) monitor and evaluate intervention performance over time to identify efficient and effective strategies. The study requires the contractor to implement an LTBI targeted testing and treatment program at their respective institution(s) in a primary healthcare setting. The contractor shall collect and provide CDC-specified data elements, including deidentified patient-level data. This requirement will be solicited as a FULL and OPEN Competition. It will use NAICS code 541690 – Other Scientific and Technical Consulting Services with a small business size standard of $16.5 Million. Any incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2021-05, effective March 10, 2021. The CDC anticipates a Cost-Reimbursement contract with a base 18-month period, plus three (3) 12-month option periods. The complete solicitation document, and reference material, if applicable, is anticipated to be available for downloading at Beta.SAM.gov on or about May 26, 2021 and proposals are anticipated to be due on or about June 26, 2021. No verbal or written requests for copies will be accepted. To be eligible to receive an award resulting from this solicitation, the contractor must be registered in the System for Award Management (SAM). To register, apply via the Internet at http://www.sam.gov. For questions on registration contact Federal Service Desk at 866-606-8220. Contractors are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback with respect to any information submitted. RESPONSES TO THIS NOTICE WILL NOT BE CONSIDERED ADEQUATE RESPONSES TO A SOLICITATION.

Inactive

The Centers for Disease Control and Prevention (CDC) is seeking to identify respondents capable of developing, implementing, and evaluating intervention studies to improve identification of latent tub... The Centers for Disease Control and Prevention (CDC) is seeking to identify respondents capable of developing, implementing, and evaluating intervention studies to improve identification of latent tuberculosis infection (LTBI) and treatment-to-cure for high-risk non-U.S.-born populations in primary care settings. Please review the attached Sources Sought document and attached draft SOW for more information.